DERMATOMYOSITIS (DM)
Clinical trials for DERMATOMYOSITIS (DM) explained in plain language.
Never miss a new study
Get alerted when new DERMATOMYOSITIS (DM) trials appear
Sign up with your email to follow new studies for DERMATOMYOSITIS (DM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets immune attack in six diseases
Disease control Recruiting nowThis early-stage trial tests a new drug called RAY121 in 144 adults with one of six immune diseases: antiphospholipid syndrome, bullous pemphigoid, Behçet's syndrome, dermatomyositis, immune-mediated necrotizing myopathy, or immune thrombocytopenia. The drug blocks a part of the …
Matched conditions: DERMATOMYOSITIS (DM)
Phase: PHASE1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated May 26, 2026 09:03 UTC
-
Fish oil fights rare muscle disease: new trial launches
Disease control Recruiting nowThis study tests whether omega-3 fatty acid supplements from fish oil can reduce disease activity in adults with dermatomyositis, a rare autoimmune condition causing muscle weakness and skin rashes. About 300 participants will take either fish oil capsules or a placebo for 6 mont…
Matched conditions: DERMATOMYOSITIS (DM)
Phase: PHASE2 • Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Disease control
Last updated May 26, 2026 08:57 UTC